Blog

Ruben Mesa and Srdan Verstovsek

Jan 14, 2025, 02:23

ASH2024 Insights from Ruben Mesa and Srdan Verstovsek

Peter Loffelhardt, Founder and CEO of Global MPN Scientific Foundation, shared a post on LinkedIn:

” Exclusive ASH2024 Insights from Prof. Ruben Mesa and Prof. Srdan Verstovsek!

This week, I had the honor of moderating an insightful discussion with two of the world’s leading experts in MPN research. Together, we explored the latest advancements and breakthroughs shaping the future of MPN care.

This session offered valuable perspectives for patients, caregivers, and healthcare professionals alike. Don’t miss the opportunity to gain exclusive insights into what’s ahead for MPN treatment and management.

Watch the full video now.”

ASH2024 cancer fight against cancer Global fight against cancer Global MPN Scientific Foundation MPN research OncoDaily Oncology Ruben Mesa Srdan Verstovsek

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers